InterCure Ltd.
INCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $238,845 | $355,553 | $388,684 | $219,677 |
| % Growth | -32.8% | -8.5% | 76.9% | – |
| Cost of Goods Sold | $208,612 | $250,458 | $233,601 | $128,546 |
| Gross Profit | $30,233 | $105,095 | $155,083 | $91,131 |
| % Margin | 12.7% | 29.6% | 39.9% | 41.5% |
| R&D Expenses | $414 | $388 | $632 | $1,235 |
| G&A Expenses | $62,921 | $64,300 | $91,721 | $45,303 |
| SG&A Expenses | $84,631 | $86,237 | $97,318 | $53,464 |
| Sales & Mktg Exp. | $21,710 | $21,937 | $5,597 | $8,161 |
| Other Operating Expenses | $12,396 | $60,037 | $6,506 | $8,247 |
| Operating Expenses | $97,441 | $146,662 | $104,456 | $62,946 |
| Operating Income | -$67,208 | -$41,567 | $50,627 | $28,188 |
| % Margin | -28.1% | -11.7% | 13% | 12.8% |
| Other Income/Exp. Net | -$20,115 | -$19,718 | -$6,785 | -$9,451 |
| Pre-Tax Income | -$87,323 | -$61,285 | $43,842 | $18,737 |
| Tax Expense | -$14,530 | $2,248 | $93 | $11,441 |
| Net Income | -$67,795 | -$61,959 | $44,819 | $4,690 |
| % Margin | -28.4% | -17.4% | 11.5% | 2.1% |
| EPS | -1.42 | -1.36 | 0.99 | 0.12 |
| % Growth | -4.4% | -237.4% | 725% | – |
| EPS Diluted | -1.42 | -1.36 | 0.99 | 0.11 |
| Weighted Avg Shares Out | 47,767 | 45,558 | 45,353 | 38,493 |
| Weighted Avg Shares Out Dil | 47,767 | 45,573 | 45,353 | 40,839 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,700 | $4,547 | $844 | $130 |
| Interest Expense | $20,645 | $24,219 | $14,689 | $5,045 |
| Depreciation & Amortization | $15,371 | $13,166 | $11,699 | $7,393 |
| EBITDA | -$51,307 | -$23,900 | $70,230 | $31,172 |
| % Margin | -21.5% | -6.7% | 18.1% | 14.2% |